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Abstract
Drug resistance represents one of the main problems for the use of chemotherapy to treat
leishmaniasis. Additionally, it could provide some advantages to Leishmania parasites,
such as a higher capacity to survive in stress conditions. In this work, in mixed populations
of Leishmania donovani parasites, we have analyzed whether experimentally resistant lines
to one or two combined anti-leishmanial drugs better support the stress conditions than a
susceptible line expressing luciferase (Luc line). In the absence of stress, none of the Leish-
mania lines showed growth advantage relative to the other when mixed at a 1:1 parasite
ratio. However, when promastigotes from resistant lines and the Luc line were mixed and
exposed to different stresses, we observed that the resistant lines are more tolerant of differ-
ent stress conditions: nutrient starvation and heat shock-pH stress. Further to this, we ob-
served that intracellular amastigotes from resistant lines present a higher capacity to
survive inside the macrophages than those of the control line. These results suggest that re-
sistant parasites acquire an overall fitness increase and that resistance to drug combina-
tions presents significant differences in their fitness capacity versus single-drug resistant
parasites, particularly in intracellular amastigotes. These results contribute to the assess-
ment of the possible impact of drug resistance on leishmaniasis control programs.
Author Summary
Chemotherapy is currently the only treatment option for leishmaniasis, a neglected tropical
disease produced by the protozoan parasite Leishmania. However, first-line drugs have dif-
ferent types of limitations including toxicity, price, efficacy and mainly emerging resistance.
TheWHO has recently recommended a combined therapy in order to extend the life ex-
pectancy of these compounds. The emergence and spread of Leishmania antimonial-
resistant parasites have led to a high rate of antimonial failure in India and have raised
questions about the selection and propagation risk of drug resistant parasites. The spread of
drug-resistant parasites in the field probably depends on their transmission potential,
which is influenced by, among other factors, the relative fitness of drug-resistant versus
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003704 April 7, 2015 1 / 12
a11111
OPEN ACCESS
Citation: García-Hernández R, Gómez-Pérez V,
Castanys S, Gamarro F (2015) Fitness of Leishmania
donovani Parasites Resistant to Drug Combinations.
PLoS Negl Trop Dis 9(4): e0003704. doi:10.1371/
journal.pntd.0003704
Editor: Louis Maes, University of Antwerp, BELGIUM
Received: January 16, 2015
Accepted: March 15, 2015
Published: April 7, 2015
Copyright: © 2015 García-Hernández et al. This is
an open access article distributed under the terms of
the Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was supported by Plan Andaluz
de Investigación (Proyecto de Excelencia CTS-7282),
Junta de Andalucia (FG). Spanish Grants SAF2012-
34267 (to FG) and SAF2011-28102 (to SC).
Subdirección General de Redes y Centros de
Investigación Cooperativa-FEDER, RICET project
RD12/0018/0017 (FG). The funders had no role in
study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
drug-susceptible parasites. In light of this, we have designed experimental studies to deter-
mine whether Leishmania donovani parasites resistant to single and combinations of anti-
leishmanial drugs present any advantages in their ability to bear the different stress condi-
tions versus a susceptible L. donovani line. Our results suggest that resistant parasites ac-
quire an overall fitness increase and that resistance to drug combinations presents
significant differences in their fitness capacity, particularly in intracellular amastigotes.
Introduction
Leishmaniasis, a neglected tropical parasitic disease that is prevalent in 98 countries spread
across three continents, is caused by protozoan parasites belonging to the genus Leishmania
[1]; visceral leishmaniasis (VL), caused by species of the Leishmania donovani complex, is a le-
thal disease if left untreated. The recommended first-line therapies for VL include: i) pentava-
lent antimonials (meglumine antimoniate and sodium stibogluconate), except in some regions
in the Indian subcontinent where there are significant areas with drug resistance [2]; ii) the
polyene antibiotic amphotericin B or the liposomal amphotericin B formulation AmBisome;
iii) the aminoglycoside paromomycin; and iv) the oral drug miltefosine. Although WHO [1, 3]
recommended the use of either a single dose of AmBisome or combinations of anti-leishmanial
drugs in order to reduce the duration and toxicity of treatment, to prolong the therapeutic life-
span of existing drugs and to delay the emergence of resistance, recent experimental findings
have demonstrated the ability of Leishmania to develop experimental resistance to different
drug combinations [4]. The emergence and spread of Leishmania antimonial-resistant para-
sites have led to a high rate of antimonial failure in India [5] and have raised questions about
the selection and propagation risk of drug resistant parasites [6, 7]. The spread of drug-
resistant parasites in the field probably depends on their transmission potential, which is influ-
enced by, among other factors, the relative fitness of drug-resistant versus drug-susceptible
parasites.
Previous results have demonstrated that the acquisition of drug resistance could have an im-
pact on parasite fitness, which could in turn influence other important biological properties in-
volved in the regulation of proliferation and differentiation of parasites [6, 8]. As defined
previously [6, 9], the fitness of Leishmania parasites can be measured by: i) capacity to survive,
grow and generate infective metacyclic forms in the vector, ii) capacity to survive and grow in
the mammalian host, and iii) capacity of transmission between the host and the vector.
Throughout its natural life cycle, Leishmania encounters adverse conditions that include: i)
nutrient starvation and acidification of the medium, conditions that induce metacyclogenesis
[10], ii) heat shock, when the parasite moves from growth at 28°C in the sandfly to 37°C inside
the mammalian host macrophage, and iii) reactive oxygen species (ROS) and reactive nitrogen
species (RNS), when it is phagocytized by macrophages of the host [11, 12]. Leishmania has
evolved a broad spectrum of mechanisms to protect itself against these host defenses, including:
i) enzymes that detoxify ROS and RNS [13], ii) use of thiols as antioxidant defenses [14], and
iii) inhibition of the host's oxidative defense mechanisms [15].
However, it is not strictly true that all of the above increased the fitness capacity of all L.
donovani resistant strains, as some strains showed little or no difference in their in vivo survival
capacity compared to antimony-sensitive strains [16]. As suggested, other factors such as the
genetic background of parasites could be important in the in vivo fitness capacity of L. dono-
vani isolates that are clinically resistant to antimonials [16].
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In this work, we evaluate whether L. donovani lines that are experimentally resistant to sin-
gle anti-leishmanial drugs [amphotericin B (AmB), miltefosine (MIL), paromomycin (PMM)
and trivalent antimony (SbIII)] and to drug combinations (AmB-MIL, AmB-PMM, AmB-SbIII,
MIL-PMM and SbIII-PMM), present any advantages in their ability to bear the different stress
conditions with respect to susceptible cells expressing the luciferase gene (Luc gene). For this
purpose, we have studied the susceptibility of mixed promastigote populations under different
stress conditions and their ability to infect and survive in mouse peritoneal macrophages. The
results of this study using parasites that are experimentally resistant to single and multi-drug
combinations are discussed in relation with their potential impact on future leishmaniasis
control programs.
Materials and Methods
L. donovani culture conditions
L. donovani promastigotes (MHOM/ET/67/HU3) and the previously described derivative re-
sistant lines A, M, P, S, AM, AP, AS, MP, and SP (resistant to AmB, MIL, PMM, SbIII, AmB
+MIL, AmB+PMM, AmB+SbIII, MIL+PMM and SbIII+PMM, respectively) [4] were grown at
28°C in an RPMI 1640-modified medium (Invitrogen) supplemented with 20% heat-inacti-
vated fetal bovine serum (hiFBS, Invitrogen). L. donovani with the luciferase gene integrated
into the parasite genome (Luc line) was grown in the same conditions.
Obtention of a bioluminescent L. donovani line
Phothinus pyralis luciferase gene (luc) was amplified from vector pX63NEO-3Luc [17] by PCR
using the primers LucNcoIF 5’-GACGCCCATGGATGGAAGACGCCAAAAACAT-3’ and
LucNotIR 5’-GACGTAGCGGCCGCTTACAATTTGGACTTTCCGC-3’ including (in bold)
NcoI and NotI restriction sites, respectively. The luc gene was then cloned into the NcoI-NotI
sites of vector pLEXSY-hyg2 (Jena bioscience, Jena, Germany) which harbor a marker gene for
selection with hygromycin-B (hyg gene). The vector generated was denominated pLEXSYHyg-
Luc. In this construct, sequences of the 18S rRNA gene flanked the luc and hyg genes. Following
linearization with SwaI, stationary promastigotes were transfected with 3 μg of linearized pLEX-
SYHyg-Luc plasmid to integrate the luc and hyg genes into the 18S rRNA (ssu) locus by homolo-
gous recombination, using a previously described protocol [18]. Twenty-four hours after
transfection, the culture medium was supplemented with 25 μg/mL of hygromycin-B. Hygro-
mycin-resistant parasites were usually selected after 7 days. After establishing the transgenic
parasites, they were plated onto 1.5% agar plates containing culture medium plus 100 μg/mL
hygromycin-B. After 10 days incubating at 28°C, clones were selected on agar plates and further
propagated in liquid RPMI-modified medium supplemented with 100 μg/mL hygromycin-B.
Integration of the expression cassette into the ssu locus was confirmed by PCR using genomic
DNA from the wild-type (WT) and transgenic strains of L. donovani (Luc line) as a template.
For this purpose, we used primer pairs ssu forward primer F3001 5’-GATCTGGTT-
GATTCTGCCAGTAG-3’ and 5’ utr (aprt) reverse primer A1715 5’-TATTCGTTGTCA-
GATGGCGCAC-3’, and primer pairs hyg forward primer A3804 5’-CCGATGGCTGTGT-
AGAAGTACTCG-3’ and ssu reverse primers 3002 5’-CTGCAGGTTCACCTACAGCTAC-3’.
Measurement of luciferase activity
Promastigotes and amastigotes isolated as described previously [19], were resuspended in HBS
buffer (21 mMHEPES, 0.7 mM Na2HPO4, 137 mMNaCl, 5 mM KCl, and 6 mM D-glucose,
pH 7.1) supplemented with 25 μM cell-permeable DMNPE-luciferin. After 15 minutes at room
Fitness of Drug-Resistant Leishmania Parasites
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temperature, aliquots of this suspension (100 μL/well) were distributed into 96-well white poly-
styrene microplates. Luminescence was recorded with an Infinite F200 microplate reader
(Tecan Austria GmbH, Austria). To measure the luciferase activity of intracellular amastigotes
contained within infected cells, the Luciferase Assay System (Promega, Madison, Wis) was
used according to the instructions of the manufacture. Luminescence was measured in the Infi-
nite F200 microplate reader immediately after mixing.
Determination of growth curve of mixed L. donovani lines
Log-phase promastigotes from the control (WT) and A, M, P, S, AM, AP, AS, MP and SP resis-
tant lines were mixed in a 1:1 ratio with log-phase promastigotes from the Luc line (1x106
mixed parasites/mL). Parasite density was microscopically determined every 24 h for a total of
144 h using Neubauer count chambers in order to monitor the growth. Parasite density in the
WT line plus Luc line mixture was used as a control. Also, we evaluated the growth of each line
in these mixed populations after 144 h of incubation, determining the luminescence as a mea-
sure of the cellular density of the Luc line. All growth experiments with the different parasite
lines were performed in triplicate. In parallel, the mixed populations at a 1:1 ratio (4x106 mixed
parasites/mL) were sub-cultured every 48 h (logarithmic phase) and luminescence measured at
the end of the first and second sub-culture.
Proliferation of mixed L. donovani promastigote populations after
different stress conditions
Promastigotes from the WT and resistant lines were mixed with the Luc line in a 1:1 ratio
(4x106 mixed parasites/mL), and the proliferation of resistant parasites exposed to different
stress conditions (late stationary growth phase, starvation and heat shock plus pH modifica-
tion) was compared to the Luc line by measuring the luminescence intensity. The mixture of
the WT and Luc lines was used as a control for all experiments.
Late stationary phase growth profile. Promastigotes from resistant lines plus the Luc line
or mixed WT plus Luc lines were cultured for 7 days and then sub-cultured for 48 h. Thereaf-
ter, an aliquot was used to determine the luminescence, and the remaining mixed population
was kept for a further 5 days. A second sub-culture was performed and the luminescence deter-
mined after 48 h.
Starvation stress. We evaluated the proliferation capacity of mixed populations in starva-
tion conditions by incubating parasites in a serum-free medium for 24 h. 20% hiFBS was then
added to the medium and parasites were incubated for 48 h before determining the lumines-
cence. The remaining mixed populations were subjected to the same stress once more, sub-
cultured for 48 h in complete medium and the luminescence measured.
Heat shock and pH stresses. The mixed populations of parasites were incubated at 37°C
for 24 h in an acidified culture medium, pH 5.4. The promastigotes were then diluted in culture
medium, incubated for 48 h at 28°C and the luminescence was determined. Parasites were sub-
jected to a second cycle of heat shock and pH stress before measuring the luminescence.
Proliferation of mixed intracellular amastigote populations
For experiments studying intracellular amastigotes, mouse peritoneal macrophages were ob-
tained as described previously [20] and plated at a density of 3 x 104 or 3 x 105 macrophages/
well in 96-well white polystyrene microplates or 24-well tissue culture chamber slides, respec-
tively, in an RPMI 1640 medium supplemented with 10% hiFBS, 2 mM glutamate, penicillin
(100 U/mL) and streptomycin (100 μg/mL). Promastigotes from resistant or WT lines were
mixed with the Luc line 1:1 ratio and maintained in culture for 6 days. Afterwards, the mixed
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populations of stationary phase cultures were used to infect macrophages at a macrophage/par-
asite ratio of 1:10. Six hours after infection at 35°C and 5% CO2, extracellular parasites were re-
moved by washing with serum-free medium. Infected macrophages were maintained in culture
medium at 37°C with 5% CO2 for 24 h and 96 h. To determine the infection index (% infection
x amastigotes/macrophages), infected macrophages maintained in 24-well plates were fixed for
30 min at 4°C with 2.5% paraformaldehyde in PBS buffer (1.2 mM KH2PO4, 8.1 mM
Na2HPO4, 130 mMNaCl, and 2.6 mM KCl, adjusted to pH 7), and permeabilized with 0.1%
Triton X-100 in PBS for 30 min. Intracellular parasites and macrophages were detected by nu-
clear staining with ProLong Gold antifade reagent plus DAPI. To determine the intracellular
proliferation profile of each line, infected macrophages maintained in 96-well plates were lysed
and then the luminescence measured using the Luciferase Assay System (Promega).
Animals
Eight-week-old male BALB/c mice were purchased from Charles River Breeding Laboratories
and maintained in our Animal Facility Service under pathogen-free conditions. They were fed
a typical rodent diet and given drinking water ad libitum. These mice were used to collect pri-
mary peritoneal macrophages.
Ethics statement
All experiments were performed according to National/EU guidelines regarding the care and
use of laboratory animals in research. Approval for these studies was obtained from the Ethics
Committee of the Spanish National Research Council (CSIC, file CEA-213-1-11).
Statistical analysis
Statistical comparisons between groups were performed using Student’s t-test. Differences
were considered significant at a level of p<0.05.
Results and Discussion
Luciferase expression in promastigotes and intracellular amastigotes of
L. donovani: A useful tool for measuring fitness
The firefly luciferase (Luc) [21] has proved to be a useful reporter gene for monitoring gene ex-
pression [22] and quantifying Leishmania infections in macrophages and animal models, with
the overall aim of probing host-microbe interactions [23, 24]. To assess the feasibility of using
bioluminescence as a quantitative indicator of parasite proliferation, studies were performed to
correlate bioluminescence with parasite number. For this purpose, the Luc gene was amplified
by PCR and cloned into pLEXSY-hyg2. The LUC-expressing vector was electroporated into
L. donovani parasites which were then selected in the presence of hygromycin-B. To test
whether luciferase activity correlated well with parasite number, 4-fold serial dilutions were
prepared and their luciferase activity measured. An excellent linear correlation was observed
between the number of transgenic promastigotes and the luminescence intensity (S1 Fig).
Transfectant parasites that overexpress luciferase (from now on, Luc line) were also tested
for their ability to infect macrophages. Stationary-phase recombinant promastigotes were used
to infect mouse peritoneal macrophages. Intracellular Leishmania infection was observed mi-
croscopically after DAPI staining and no significant differences were noted in the infectivity of
the Luc line versus the WT line (S2A Fig). Furthermore, an excellent correlation was observed
between amastigote numbers and luminescence intensity (S2B Fig). Collectively, these results
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strongly suggest that the Luc line constitutes a valuable tool for assessing the viability and dy-
namics of mixed populations.
Leishmania growth profile of mixed populations
The promastigote number was evaluated every day for 6 days so that the growth features of
each resistant line, or the WT line mixed in a 1:1 parasite ratio with the Luc line, could be stud-
ied and compared. We found that all mixed populations showed a similar growth profile as the
control (WT+Luc) (Fig 1A). Moreover, the luminescence values were similar for each of these
mixed populations after the 6th day of culture (Fig 1B). These results clearly indicate that the
Luc line was present in the same ratio in all mixed populations and, therefore, there was no pre-
dominance of one line over another line under these conditions.
Proliferation of mixed Leishmania populations after exposure to different
stress conditions
To evaluate whether there was predominance of any resistant lines over the susceptible Luc
line, promastigotes from resistant lines and the Luc line were mixed in a 1:1 parasite ratio and
grown without stress or exposure to different stresses. To assess the growth recovery, the lumi-
nescence intensity of mixed populations was determined in all cases after 48 h of culture in
standard conditions. The WT plus Luc lines (WT+Luc) mixture was used as a control. The
total number of mixed parasite cultures shows no significant differences between WT+Luc and
the resistant lines+Luc in the different stress conditions, ranging indistinctly between 22-
32x107 mixed parasites/mL.
Without nutritional stress. Mixed populations were sub-cultured every 48 h to maintain
continuous logarithmic growth and adequate nutritional requirements. After two sub-cultures,
luminescence analysis did not reveal any significant differences between mixed populations in
relation to controls (ranging from 90 to 118% indistinctly). Therefore, in the absence of nutri-
tional stress, none of the Leishmania lines showed growth advantage relative to the others.
Late stationary phase assays. Major factors determining entry into the stationary phase
are pH and the availability of nutrients. Parasite multiplication during culture causes consump-
tion of nutrients resulting in nutrient deficiency and medium acidification, conditions that are
known to induce metacyclogenesis [10]. To assess the response during the late stationary phase
after two successive culture cycles, mixed populations were maintained for 7 days, sub-cultured
and then the luminescence determined. All mixed populations exhibited a similar reaction to
stress at the first sub-culture, showing a similar luminescence value (Fig 2, black columns).
Fig 1. Growth profile of mixed promastigotes populations of Leishmania lines. (A) Log-phase
promastigotes fromWT and resistant lines were mixed at a 1:1 parasite ratio (1x106 parasites/ml) with log-
phase promastigotes from Luc line (Luc), and the number of parasites were monitored every 24 h. (B)
Luminescence of 107 promastigotes frommixed populations was determined after 6 days of incubation in
standard culture medium. Results are the average of three independent experiments ± SD. Horizontal line
indicates the threshold at which luminescence levels have been modified with respect to control (WT+Luc).
doi:10.1371/journal.pntd.0003704.g001
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However, in the second sub-culture event, a significant decrease in luminescence with respect
to the control was observed for all mixed populations, except for that containing the M line
(Fig 2, gray columns). The lines that showed a higher ratio of growth were P, S and AM, since
the mixed populations P+Luc, S+Luc, and AM+Luc had luminescence values of 51%, 76% and
82%, respectively, versus the 100% luminescence of the mixture WT+Luc (Fig 2, horizontal
line). These results suggested that the resistant lines are more tolerant to stress conditions pres-
ent in the late stationary phase than the Luc line, because their higher growth rates are respon-
sible for the displacement mentioned above. Also note that the AM resistant line has an
increased growth rate compared to the single-drug resistant lines A and M (Fig 2, gray col-
umns). The different growth profiles observed could be due to the metabolic adaptations which
all converge on the higher tolerance of the resistant lines to stress conditions, as recently de-
scribed [25].
Starvation. We assessed the proliferation capacity of mixed Leishmania populations
under starvation conditions. This was to determine whether the predominance of resistant
lines observed during the stationary phase was only due to a difference in starvation stress tol-
erance or due to all of the stresses that occur during the stationary phase of growth. For this
purpose, we incubated mixed populations in serum-free medium for 24 h. Then we monitored
the luminescence in complete media and the remaining mixed populations were subjected to
the same stress once more before the analysis. After the first cycle, all resistant lines, except M
and P lines, predominate over the susceptible Luc line (Fig 3, black columns), with significantly
higher differences existing after the second starvation cycle (Fig 3, gray columns). S and AP
Leishmania lines showed a marked predominance over the Luc line, since the S+Luc and AP
+Luc populations exhibited luminescence values relative to the control (WT+Luc) of 64% and
66%, respectively (Fig 3, horizontal line). However, the comparison of single- and dual-drug re-
sistant lines indicated a greater advantage for all dual resistant lines (except for the AS line)
when compared to any of their respective single-drug resistant lines (Fig 3). These results sug-
gest that, in the absence of nutrients, the resistant lines, and more specifically those resistant to
drug combinations, present higher survival rates than the susceptible Luc line since they are
Fig 2. Leishmania resistant lines are more tolerant to stress in the late stationary growth phase.
Promastigotes fromWT and resistant lines were mixed at a 1:1 parasite ratio with promastigotes from Luc line
(Luc), maintained in standard culture medium for 7 days and the luminescence of 107 promastigotes was
determined at 48 h of the first (black columns) and second (gray columns) sub-culture cycle. Results are the
average of four independent experiments ± SD. Statistically differences using Student's t test are indicated
relative to the control values (*, p<0.05; **, p<0.01; ***, p<0.005; ****, p<0.001). Horizontal line indicates
the threshold at which luminescence levels have been modified with respect to control (WT+Luc).
doi:10.1371/journal.pntd.0003704.g002
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able to adapt their energy metabolism to better cope with starvation, presumably by increasing
their tolerance to this stress.
Heat shock plus pH stress. The survival capacity of promastigotes is not only determined
by their nutrient needs, but also by their capacity to resist stresses encountered inside the mac-
rophages, such as acidic pH and high temperatures. In this experiment mixed populations
were exposed to two culture cycles at 37°C and pH 5.4 for 24 h and luminescence determined
in standard culture conditions. Under these stress conditions, we observed that all the resistant
Fig 3. Leishmania resistant lines show higher survival in starvation. Promastigotes fromWT and
resistant Leishmania lines were mixed at a 1:1 parasite ratio with promastigotes from Luc line (Luc), incubated
in serum-free medium for 24 h, supplemented with 20% hiFBS and the luminescence of 107 promastigotes
was determined at 48 h of the first (black columns) and second (gray columns) starvation cycle. Results are the
average of four independent experiments ± SD. Statistically differences using Student's t test are showed
relative to the control values (*, p<0.05; **, p<0.01; ***, p<0.005; ****, p<0.001). Horizontal line indicates
the threshold at which luminescence levels have been modified with respect to control (WT+Luc).
doi:10.1371/journal.pntd.0003704.g003
Fig 4. Leishmania resistant lines are more tolerant to heat shock and pH stress.Mixed promastigotes
fromWT and resistant lines at a 1:1 parasite ratio were incubated in culture medium, pH 5.4 at 37 ºC for 24 h.
Then, mixed populations were incubated at 28 ºC and pH 7.2 and luminescence of 107 promastigotes was
evaluated at the first (black columns) and second (gray columns) stress cycle. Results are the average of four
independent experiments ± SD. Statistically differences using Student's t test are showed relative to the
control values (*, p<0.05; **, p<0.01; ***, p<0.005; ****, p<0.001). Horizontal line indicates the threshold
at which luminescence levels have been modified with respect to control (WT+Luc).
doi:10.1371/journal.pntd.0003704.g004
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lines predominated over the Luc line at both cycles (Fig 4, black and gray columns respective-
ly), except the AM and AP lines, and the AS line which only predominated over the Luc line
after the second cycle (Fig 4, gray columns). This observation could be associated with the fact
that resistance to drug combinations AmB plus other anti-leishmania drugs (MIL, PMM and
SbIII) confer metabolic changes associated with the loss of this advantage. This interesting ob-
servation will be considered in future studies to gain more inside about the possible effect of
AmB in the resistant phenotype of drug combinations. Luminescence values with respect to
the control (WT+Luc) for mixed populations ranged from 27 to 77%, for P+Luc to AS+Luc
populations, respectively. Furthermore, none of the dual-drug resistant lines exhibited a higher
fitness than their respective single-drug resistant lines (Fig 4). These results suggest that resis-
tant lines are more tolerant to heat shock and pH stress conditions than the Luc line, which
could facilitate a higher survival rate inside the macrophage and an increased capacity to deal
with the natural stresses that the parasites face throughout their life cycle.
Proliferation of mixed intracellular amastigotes populations
Within the mammalian host, Leishmania promastigotes differentiate into amastigotes and
multiply predominantly inside macrophages, where they are exposed to stress, including star-
vation, acidic pH, high temperatures (heat shock) and ROS and RNS production [11, 26]. To
determine whether intracellular amastigotes from resistant lines were able to displace in vitro
intracellular amastigotes from the susceptible Luc line, macrophages were infected with mixed
populations of promastigotes taken from 6 day-old cultures where, as shown in Fig 1, no differ-
ences were observed in proliferation and the Luc line ratio. The infection index and lumines-
cence of intracellular amastigotes were determined at 24 and 96 h post-infection to assess their
infectivity and survival rates in mouse peritoneal macrophages. The infection indexes were
similar in all cases, with values ranging for 24 h between 183±22 and 234±28, and for 96 h be-
tween 182±27 and 250±34. The results showed that in the early stage of macrophage infection
(24 h) all the resistant lines, except the M line, had a significant predominance over the Luc
line compared to the control (Fig 5A). The different lines showed a range of luminescence be-
tween 31 and 63% from SP+Luc and S+Luc populations, respectively, compared to the control
(Fig 5A). These results could be due to: i) a higher percentage of metacyclic parasites, ii) toler-
ance to oxidative stress, and/or iii) tolerance to acidic pH and high temperatures of the resistant
lines compared to the susceptibility of the Luc line. Also, in the late stage of infection (96 h),
Fig 5. Intracellular amastigotes of Leishmania resistant lines present higher capacity to survive in
mouse peritoneal macrophages.Mouse peritoneal macrophages were plated in 96-well white polystyrene
microplates and infected during 6 h with promastigotes of 6 days of culture from resistant or WT lines mixed
with Luc line. Infected macrophages were maintained in culture medium at 37°C with 5% CO2 during 24 h (A)
or 96 h (B) and luminescence was determined and normalized by infection index. Results are the average of
three independent experiments ± SD. Statistically differences using Student's t test are showed relative to the
control values (*, p<0.05; **, p<0.01; ***,p<0.001). Horizontal line indicates the threshold at which
luminescence levels have been modified with respect to control (WT+Luc).
doi:10.1371/journal.pntd.0003704.g005
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the resistant lines, again with the exception of the M line, were able to fully benefit from their
initial advantage (Fig 5B). They showed a range of luminescence between 27 and 68% from SP
+Luc and A+Luc populations, respectively, compared to the luminescence produced by the
control (Fig 5B). Additionally, there were no significant differences on predominance of resis-
tant lines between 24 and 96 h, with the exception of the S line (p<0.05). These results suggest
that the predominance of some resistant lines over the Luc line is the result of a higher infection
rate during the initial stage which reflects as a higher survival rate of intracellular amastigotes
within macrophages.
Leishmania have successfully adapted to different environments for thousands of years and
developed a highly flexible nature. Their survival capacity mainly relies on their ability to sup-
press oxidative outbursts of the host defense mechanism [15] and on a unique oxidant-protective
redox metabolism, where thiols play a key role in antioxidant defenses [14]. In this regard, we
have previously described that the resistant lines, except the M and S lines, had higher non-
protein thiol levels than the WT line [4], which could contribute to a greater parasite survival
rate within the host macrophages.
It has been demonstrated that some L. donovani strains resistant to antimonials have a
more variable and markedly higher capacity of in vivo infection compared to antimony suscep-
tible Leishmania strains [16]. Strains resistant to antimony also have a higher metacyclogenic
capacity [27] and have specifically evolved extra mechanisms to manipulate their host cells in
order to avoid antimony-induced stress [28]. Such adaptations would not only improve the
parasites survival capacity when stressed by antimony, but would also favor their survival in
drug-free conditions.
Since SbIII, AmB and MIL kill Leishmania through a common cell death pathway to achieve
apoptosis, strains resistant to one or more of these drugs could develop tolerance to apoptosis,
which would grant them a higher survival rate in macrophages, as we have observed with our
Leishmania resistant lines (Fig 5B).
In conclusion, the experiments using our transgenic Leishmania luc line have clearly dem-
onstrated and validated the fact that Leishmania lines experimentally resistant to individual
and combinatorial anti-leishmanial drugs have an increased fitness compared to Leishmania
susceptible lines, probably as a consequence of their metabolic adaptations which all converge
on the higher tolerance to stress conditions, as recently described [25]. Subsequently, they also
have a better chance of survival. However, although this approach using promastigotes for as-
sessing the viability and dynamics of mixed populations have important advantages, their use
on intracellular amastigotes has some methodological limitations. Therefore, the emergence
and spread of drug-resistant parasites in the field will probably result in a greater competitive
fitness cost with respect to susceptible parasites, plus negative effects on the chemotherapy
strategies used to control leishmaniasis.
Supporting Information
S1 Fig. Correlation between luciferase activity and number of promastigotes. 4-fold serial
dilutions were prepared and parasites counted microscopically using Neubauer count cham-
bers. Luminescence intensity was recorded in a.u. (arbitrary units) using an Infinite F200
microplate reader. These results represent three independent experiments.
(TIF)
S2 Fig. Infection index and correlation between luciferase activity and number of amasti-
gotes. (A) Intracellular Leishmania infection of WT and Luc lines was observed microscopical-
ly after DAPI staining. Results are the mean ± S.D. of three independent experiments. (B)
2-fold serial dilutions were prepared and parasites counted microscopically using Neubauer
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count chambers. Luminescence intensity expressed as a.u. (arbitrary units) was measured
using an Infinite F200 microplate reader. Results are representative of three independent ex-
periments.
(TIF)
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